Mathematical and computational approaches in understanding the immunobiology of granulomatous diseases

Shah, 2017, Histopathologic review of granulomatous inflammation, J Clin Tubercul Other Mycobact Dis, 7, 1, 10.1016/j.jctube.2017.02.001 Ramakrishnan, 2012, Revisiting the role of the granuloma in tuberculosis, Nat Rev Immunol, 12, 352, 10.1038/nri3211 Zumla, 1996, Granulomatous infections: etiology and classification, Clin Infect Dis, 23, 146, 10.1093/clinids/23.1.146 James, 2000, A clinicopathological classification of granulomatous disorders, Postgrad Med J, 76, 457, 10.1136/pmj.76.898.457 Hams, 2013, The schistosoma granuloma: friend or foe?, Front Immunol, 4, 89, 10.3389/fimmu.2013.00089 Pearce, 2002, The immunobiology of schistosomiasis, Nat Rev Immunol, 2, 499, 10.1038/nri843 Pearce, 2004, Th2 response polarization during infection with the helminth parasite Schistosoma mansoni, Immunol Rev, 201, 117, 10.1111/j.0105-2896.2004.00187.x Guirado, 2013, Modeling the mycobacterium tuberculosis granuloma–the critical battlefield in host immunity and disease, Front Immunol, 4, 98, 10.3389/fimmu.2013.00098 Ito, 2013, The linkage of innate and adaptive immune response during granulomatous development, Front Immunol, 4, 10, 10.3389/fimmu.2013.00010 Rodrigues, 2016, Regulation of immunity during visceral Leishmania infection, Parasites Vectors, 9, 118, 10.1186/s13071-016-1412-x Boros, 2003, The cellular immunological aspects of the granulomatous response, 1 Chen, 2007, Expression profiling in granulomatous lung disease, Proc Am Thorac Soc, 4, 101, 10.1513/pats.200607-140JG Magombedze, 2013, Latent tuberculosis: models, computational efforts and the pathogen's regulatory mechanisms during dormancy, Front Bioeng Biotechnol, 1, 4, 10.3389/fbioe.2013.00004 Magombedze, 2014, Competition for antigen between Th1 and Th2 responses determines the timing of the immune response switch during Mycobacterium avium subspecies paratuberulosis infection in ruminants, PLoS Comput Biol, 10, 10.1371/journal.pcbi.1003414 Yap, 1999, Cell-mediated immunity to Toxoplasma gondii: initiation, regulation and effector function, Immunobiology, 201, 240, 10.1016/S0171-2985(99)80064-3 O'Garra, 2013, The immune response in tuberculosis, Annu Rev Immunol, 31, 475, 10.1146/annurev-immunol-032712-095939 Zissel, 2014, Cellular activation in the immune response of sarcoidosis, 307 Zhang, 2015, Recent advances in developing vaccines against Toxoplasma gondii: an update, Expert Rev Vaccines, 14, 1609, 10.1586/14760584.2015.1098539 Ribeiro, 2017, Modeling immune response to Leishmania species indicates adenosine as an important inhibitor of Th-Cell activation, Front Cell Infect Microbiol, 7, 309, 10.3389/fcimb.2017.00309 Lopez-Yglesias, 2018, T-bet-independent Th1 response induces intestinal immunopathology during Toxoplasma gondii infection, Mucosal Immunol, 11, 921, 10.1038/mi.2017.102 Flynn, 2001, Tuberculosis: latency and reactivation, Infect Immun, 69, 4195, 10.1128/IAI.69.7.4195-4201.2001 Eum, 2010, Neutrophils are the predominant infected phagocytic cells in the airways of patients with active pulmonary TB, Chest, 137, 122, 10.1378/chest.09-0903 Kaplan, 2003, Mycobacterium tuberculosis growth at the cavity surface: a microenvironment with failed immunity, Infect Immun, 71, 7099, 10.1128/IAI.71.12.7099-7108.2003 Dheda, 2018, Drug penetration gradients associated with acquired drug resistance in tuberculosis patients, Am J Respir Crit Care Med, 10.1164/rccm.201711-2333OC Johnson, 2014, Nontuberculous mycobacterial pulmonary infections, J Thorac Dis, 6, 210 Flynn, 2005, What's good for the host is good for the bug, Trends Microbiol, 13, 98, 10.1016/j.tim.2005.01.005 Flynn, 2000, Immune responses in tuberculosis, Curr Opin Immunol, 12, 432, 10.1016/S0952-7915(00)00116-3 Cadena, 2017, Heterogeneity in tuberculosis, Nat Rev Immunol, 17, 691, 10.1038/nri.2017.69 Song, 2011, Chronic granulomatous disease: a review of the infectious and inflammatory complications, Clin Mol Allergy, 9, 10, 10.1186/1476-7961-9-10 De Ravin, 2006, Sarcoidosis in chronic granulomatous disease, Pediatrics, 117, e590, 10.1542/peds.2005-1349 Aoun, 2014, Caseating granulomas in cutaneous leishmaniasis, PLoS Neglected Trop Dis, 8, e3255, 10.1371/journal.pntd.0003255 King, 2016, Aspergillosis in chronic granulomatous disease, J Fungi, 2, 15 Magombedze, 2013, Cellular and population plasticity of helper CD4(+) T cell responses, Front Physiol, 4, 206, 10.3389/fphys.2013.00206 Ottenhoff, 2012, Vaccines against tuberculosis: where are we and where do we need to go?, PLoS Pathog, 8, e1002607, 10.1371/journal.ppat.1002607 Harrison, 2016, Phase II and phase III failures: 2013–2015, Nat Rev Drug Discov, 15, 817, 10.1038/nrd.2016.184 Jucker, 2010, The benefits and limitations of animal models for translational research in neurodegenerative diseases, Nat Med, 16, 1210, 10.1038/nm.2224 Marincola, 2011, The trouble with translational medicine, J Intern Med, 270, 123, 10.1111/j.1365-2796.2011.02402.x Vuyyuru, 2011, Human immune system mice: current potential and limitations for translational research on human antibody responses, Immunol Res, 51, 257, 10.1007/s12026-011-8243-9 Mak, 2014, Lost in translation: animal models and clinical trials in cancer treatment, Am J Transl Res, 6, 114 Flynn, 2015, Immunology studies in non-human primate models of tuberculosis, Immunol Rev, 264, 60, 10.1111/imr.12258 Russell, 2010, Tuberculosis: what we don't know can, and does, hurt us, Science, 328, 852, 10.1126/science.1184784 Flynn, 2001, Immunology of tuberculosis, Annu Rev Immunol, 19, 93, 10.1146/annurev.immunol.19.1.93 Britton, 2014, Role of the intestinal microbiota in resistance to colonization by Clostridium difficile, Gastroenterology, 146, 1547, 10.1053/j.gastro.2014.01.059 Seekatz, 2018 Theriot, 2014, Antibiotic-induced shifts in the mouse gut microbiome and metabolome increase susceptibility to Clostridium difficile infection, Nat Commun, 5, 3114, 10.1038/ncomms4114 Bucci, 2016, MDSINE: Microbial Dynamical Systems INference Engine for microbiome time-series analyses, Genome Biol, 17, 121, 10.1186/s13059-016-0980-6 Bucci, 2014, Towards predictive models of the human gut microbiome, J Mol Biol, 426, 3907, 10.1016/j.jmb.2014.03.017 Coash, 2012, Granulomatous liver diseases: a review, J Formos Med Assoc, 111, 3, 10.1016/j.jfma.2011.11.023 Loke, 2013, Sarcoidosis: immunopathogenesis and immunological markers, Int J Chronic Dis, 2013 Kaye, 2016, Lessons from other diseases: granulomatous inflammation in leishmaniasis, 249 Hawryluk, 2010, Non-infectious granulomatous diseases of the skin and their associated systemic diseases, Am J Clin Dermatol, 11, 171, 10.2165/11530080-000000000-00000 Kopf, 1996, IL-4-deficient Balb/c mice resist infection with Leishmania major, J Exp Med, 184, 1127, 10.1084/jem.184.3.1127 Carvalho, 2007, Differential immune regulation of activated T cells between cutaneous and mucosal leishmaniasis as a model for pathogenesis, Parasite Immunol, 29, 251, 10.1111/j.1365-3024.2007.00940.x Kaye, 2011, Leishmaniasis: complexity at the host–pathogen interface, Nat Rev Microbiol, 9, 604, 10.1038/nrmicro2608 Weerakoon, 2015, Advances in the diagnosis of human schistosomiasis, Clin Microbiol Rev, 28, 939, 10.1128/CMR.00137-14 Zoni, 2016, Schistosomiasis prevalence and intensity of infection in Latin America and the Caribbean countries, 1942–2014: a systematic review in the context of a regional elimination goal, PLoS Neglected Trop Dis, 10, 10.1371/journal.pntd.0004493 Wu, 2018, Diagnosis, monitoring, and control of schistosomiasis—an update, J Biomed Nanotechnol, 14, 430, 10.1166/jbn.2018.2517 Prasse, 2016, The diagnosis, differential diagnosis, and treatment of sarcoidosis, Dtsch Ärztebl Int, 113, 565 Patterson, 2018, The pathogenesis of pulmonary sarcoidosis and implications for treatment, Chest, 153, 1432, 10.1016/j.chest.2017.11.030 Gigley, 2009, Cell-mediated immunity to Toxoplasma gondii develops primarily by local Th1 host immune responses in the absence of parasite replication, J Immunol, 182, 1069, 10.4049/jimmunol.182.2.1069 Matsushita, 1993, Clinical features of pulmonary Mycobacterium kansasii infection: comparison with M. tuberculosis and M. avium complex infection, Nihon Kyobu Shikkan Gakkai zasshi, 31, 1507 Kusunoki, 1994, Detection of Mycobacterium avium, M. intracellulare and M. kansasii in sputum by two-step PCR, Kansenshogaku zasshi, 68, 42, 10.11150/kansenshogakuzasshi1970.68.42 Mostaza, 2007, Infeccion pulmonar por MAC en paciente sin factores predisponentes, Enfermedades Infecc Microbiol Clínica, 25, 356, 10.1157/13102274 Khan, 2010, Mycobacterium Avium Complex (MAC) lung disease in two inner city community hospitals: recognition, prevalence, co-infection with Mycobacterium Tuberculosis (MTB) and Pulmonary Function (PF) improvements after treatment, Open Respir Med J, 4, 76, 10.2174/1874306401004010076 Honda, 2015, Pathogenesis and risk factors for nontuberculous mycobacterial lung disease, Clin Chest Med, 36, 1, 10.1016/j.ccm.2014.10.001 Gumbo, 2010, New susceptibility breakpoints for first-line antituberculosis drugs based on antimicrobial pharmacokinetic/pharmacodynamic science and population pharmacokinetic variability, Antimicrob Agents Chemother, 54, 1484, 10.1128/AAC.01474-09 Deshpande, 2010, Ethambutol optimal clinical dose and susceptibility breakpoint identification by use of a novel pharmacokinetic-pharmacodynamic model of disseminated intracellular Mycobacterium avium, Antimicrob Agents Chemother, 54, 1728, 10.1128/AAC.01355-09 Angeby, 2011, Wild-type MIC distributions must be considered to set clinically meaningful susceptibility testing breakpoints for all bacterial pathogens, including Mycobacterium tuberculosis, Antimicrob Agents Chemother, 55, 4492, 10.1128/AAC.00232-11 Deshpande, 2011, Pharmacokinetic/pharmacodynamic-based treatment of disseminated Mycobacterium avium, Future Microbiol, 6, 433, 10.2217/fmb.11.25 Pasipanodya, 2012, New susceptibility breakpoints and the regional variability of MIC distribution in Mycobacterium tuberculosis isolates, Antimicrob Agents Chemother, 56, 5428, 10.1128/AAC.00976-12 Pasipanodya, 2012, Scientific and patient care evidence to change susceptibility breakpoints for first-line anti-tuberculosis drugs, Int J Tubercul Lung Dis, 16, 706, 10.5588/ijtld.11.0850 Toledo-Pinto, 2018, Innate immunity and host metabolism in leprosy, Front Immunol, 9, 806, 10.3389/fimmu.2018.00806 Hashish, 2018, Mycobacterium marinum infection in fish and man: epidemiology, pathophysiology and management; a review, Vet Q, 38, 35, 10.1080/01652176.2018.1447171 Tong, 2015, Staphylococcus aureus infections: epidemiology, pathophysiology, clinical manifestations, and management, Clin Microbiol Rev, 28, 603, 10.1128/CMR.00134-14 Johnson, 2005, Buruli ulcer (M. ulcerans infection): new insights, new hope for disease control, PLoS Med, 2, e108, 10.1371/journal.pmed.0020108 Moore, 2013, Functional complexity of the Leishmania granuloma and the potential of in silico modeling, Front Immunol, 4, 35, 10.3389/fimmu.2013.00035 Velikkakam, 2017, Overview of hookworm infection in humans, 121, 10.1007/978-3-319-68493-2_4 Baughman, 2011, A concise review of pulmonary sarcoidosis, Am J Respir Crit Care Med, 183, 573, 10.1164/rccm.201006-0865CI Crohn, 1967, Granulomatous diseases of the small and large bowel: a historical survey, Gastroenterology, 52, 767, 10.1016/S0016-5085(67)80063-5 Feller, 2007, Mycobacterium avium subspecies paratuberculosis and Crohn's disease: a systematic review and meta-analysis, Lancet Infect Dis, 7, 607, 10.1016/S1473-3099(07)70211-6 Gajendran, 2018, A comprehensive review and update on Crohn's disease, Dis Mon, 64, 20, 10.1016/j.disamonth.2017.07.001 Kirschner, 2017, A review of computational and mathematical modeling contributions to our understanding of Mycobacterium tuberculosis within-host infection and treatment, Curr Opin Struct Biol, 3, 170 Siewe, 2017, Granuloma formation in leishmaniasis: a mathematical model, J Theor Biol, 412, 48, 10.1016/j.jtbi.2016.10.004 Siewe, 2016, Immune response to infection by Leishmania: a mathematical model, Math Biosci, 276, 28, 10.1016/j.mbs.2016.02.015 Albergante, 2013, A Petri net model of granulomatous inflammation: implications for IL-10 mediated control of Leishmania donovani infection, PLoS Comput Biol, 9, 10.1371/journal.pcbi.1003334 DebRoy, 2017, Challenges in modeling complexity of neglected tropical diseases: a review of dynamics of visceral leishmaniasis in resource limited settings, Emerg Themes Epidemiol, 14, 10, 10.1186/s12982-017-0065-3 Hao, 2014, Mathematical model of sarcoidosis, Proc Natl Acad Sci Unit States Am, 111, 16065, 10.1073/pnas.1417789111 Chen, 2014, PET/CT imaging correlates with treatment outcome in patients with multidrug-resistant tuberculosis, Sci Transl Med, 6, 10.1126/scitranslmed.3009501 Coleman, 2014, PET/CT imaging reveals a therapeutic response to oxazolidinones in macaques and humans with tuberculosis, Sci Transl Med, 6, 10.1126/scitranslmed.3009500 Braun, 2008, 18 F-FDG PET/CT in sarcoidosis management: review and report of 20 cases, Eur J Nucl Med Mol Imag, 35, 1537, 10.1007/s00259-008-0770-9 Mandal, 2011, Mathematical models of malaria-a review, Malar J, 10, 202, 10.1186/1475-2875-10-202 Gemayel, 2017, Malaria, metabolism and mathematical models, FEBS J, 284, 2553, 10.1111/febs.14161 Reiner, 2013, A systematic review of mathematical models of mosquito-borne pathogen transmission: 1970–2010, J R Soc Interface, 10, 20120921, 10.1098/rsif.2012.0921 Burg, 2009, Mathematical modeling of viral kinetics under immune control during primary HIV-1 infection, J Theor Biol, 259, 751, 10.1016/j.jtbi.2009.04.010 Ganusov, 2011, Fitness costs and diversity of the cytotoxic T lymphocyte (CTL) response determine the rate of CTL escape during acute and chronic phases of HIV infection, J Virol, 85, 10518, 10.1128/JVI.00655-11 Ganusov, 2013, Mathematical modeling of escape of HIV from cytotoxic T lymphocyte responses, J Stat Mech (Online), 2013 Showa, 2014, A comparison of elasticities of viral levels to specific immune response mechanisms in human immunodeficiency virus infection, BMC Res Notes, 7, 737, 10.1186/1756-0500-7-737 Magombedze, 2015, Predicting the role of IL-10 in the regulation of the adaptive immune responses in Mycobacterium avium subsp. paratuberculosis infections using mathematical models, PLoS One, 10, 10.1371/journal.pone.0141539 Magombedze, 2016, Can immune response mechanisms explain the fecal shedding patterns of cattle infected with Mycobacterium avium subspecies paratuberculosis?, PLoS One, 11, 10.1371/journal.pone.0146844 Magombedze, 2017, Inferring biomarkers for Mycobacterium avium subsp. paratuberculosis infection and disease progression in cattle using experimental data, Sci Rep, 7, 44765, 10.1038/srep44765 Magombedze, 2010, Mathematical modelling of immune regulation of type 1 diabetes, Biosystems, 102, 88, 10.1016/j.biosystems.2010.07.018 Burnham, 2002 Soetaert, 2010, Inverse modelling, sensitivity and Monte Carlo analysis in R using package FME, J Stat Software, 33 Gelman, 2003, A Bayesian formulation of exploratory data analysis and goodness-of-fit testing, Int Stat Rev, 71, 369, 10.1111/j.1751-5823.2003.tb00203.x Gelman, 2004 Wood, 2017, The human microbiome in the fight against tuberculosis, Am J Trop Med Hyg, 96, 1274, 10.4269/ajtmh.16-0581 Salgado, 2016, The microbiological signature of human cutaneous leishmaniasis lesions exhibits restricted bacterial diversity compared to healthy skin, Mem Inst Oswaldo Cruz, 111, 241, 10.1590/0074-02760150436 Zimmermann, 2012, Characterization of the lung microbiome in sarcoidosis and healthy individuals with respect to host genotype, Pneumologie, 66, 10.1055/s-0032-1329839 Proal, 2013, The human microbiome and autoimmunity, Curr Opin Rheumatol, 25, 234, 10.1097/BOR.0b013e32835cedbf Crouser, 2017, Application of “omics” and systems biology to sarcoidosis research, Ann Am Thorac Soc, 14, S445, 10.1513/AnnalsATS.201707-567OT Scher, 2016, The lung microbiota in early rheumatoid arthritis and autoimmunity, Microbiome, 4, 60, 10.1186/s40168-016-0206-x Buffie, 2015, Precision microbiome reconstitution restores bile acid mediated resistance to Clostridium difficile, Nature, 517, 205, 10.1038/nature13828 Marino, 2014, Mathematical modeling of primary succession of murine intestinal microbiota, Proc Natl Acad Sci U S A, 111, 439, 10.1073/pnas.1311322111 Crouser, 2016, In Silico modeling of granulomatous diseases, Curr Opin Pulm Med, 22, 500, 10.1097/MCP.0000000000000296 Forrellad, 2013, Virulence factors of the Mycobacterium tuberculosis complex, Virulence, 4, 3, 10.4161/viru.22329 Raghavan, 2008, Secreted transcription factor controls Mycobacterium tuberculosis virulence, Nature, 454, 717, 10.1038/nature07219 Gonzalez-Perez, 2016, Deciphering the virulence factors of the opportunistic pathogen Mycobacterium colombiense, New Microbe New Infect, 14, 98, 10.1016/j.nmni.2016.09.007 Means, 1999, Human Toll-Like Receptors Mediate Cellular Activation by Mycobacterium tuberculosis, J Immunol, 163, 3920, 10.4049/jimmunol.163.7.3920